Pasar al contenido principal

SINTESIS DE NUEVOS MODULADORES DE ENZIMAS EPIGENETICAS INSPIRADOS EN LA ESTRUCTURA DE PRODUCTOS NATURALES

SAF2013-48397-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSIDAD DE VIGO
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Epigenetic polypharmacology: from combination therapy to multitargeted drugs

  • Rodríguez de Lera, Ángel
  • Ganesan, A
The modern drug discovery process has largely focused its attention in the so-called magic bullets, single chemical entities that exhibit high selectivity and potency for a particular target. This approach was based on the assumption that the deregulation of a protein was causally linked to a disease state, and the pharmacological intervention through inhibition of the deregulated target was able to restore normal cell function. However, the use of cocktails or multicomponent drugs to address several targets simultaneously is also popular to treat multifactorial diseases such as cancer and neurological disorders. We review the state of the art with such combinations that have an epigenetic target as one of their mechanisms of action. Epigenetic drug discovery is a rapidly advancing field, and drugs targeting epigenetic enzymes are in the clinic for the treatment of hematological cancers. Approved and experimental epigenetic drugs are undergoing clinical trials in combination with other therapeutic agents via fused or linked pharmacophores in order to benefit from synergistic effects of polypharmacology. In addition, ligands are being discovered which, as single chemical entities, are able to modulate multiple epigenetic targets simultaneously (multitarget epigenetic drugs). These multiple ligands should in principle have a lower risk of drug-drug interactions and drug resistance compared to cocktails or multicomponent drugs. This new generation may rival the so-called magic bullets in the treatment of diseases that arise as a consequence of the deregulation of multiple signaling pathways provided the challenge of optimization of the activities shown by the pharmacophores with the different targets is addressed., Ministerio de Economía y Competitividad | Ref. SAF2013-48397-R, Xunta de Galicia | Ref. 2013/007
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

An improved statistical approach for conformational analysis from 13C NMR chemical shifts

  • Cotos Yáñez, Tomas Raimundo
  • Pérez González, Ana
  • Iglesias Antelo, Maria Beatriz
  • Muñoz López, Luis
Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG, In this article we propose an improved statistical approach for the estimation of the mole fraction of each conformer in a given conformational equilibrium from the measured averaged 13C NMR chemical shifts. As each compound has a different number of conformers, an iterative process of fitting (backfitting type) is necessary. In each iteration, two estimates are made, i) fitting to a ridge regression model with equality and inequality constraints and selection of variables for each compound and ii) re-fitting for all compounds. This new procedure leads to consistent results, with low standard error and good p-values, allowing the estimation of the conformational composition for small molecules with a reduced number of conformers., Ministerio de Economía y Competitividad | Ref. SAF2013-48397-R, Ministerio de Economía y Competitividad | Ref. SAF2016-77620-R, Ministerio de Economía y Competividad | Ref. MTM2016-76969-P, Agencia Estatal de Investigación | Ref. MTM2017-89422-P, Agencia Estatal de Investigación | Ref. CTQ2017-85919-R